Literature DB >> 2659998

Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor.

R Hoffman1, R A Briddell, K van Besien, E F Srour, T Guscar, N W Hudson, A Ganser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2659998     DOI： 10.1056/NEJM198907133210207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease.

Authors:  Min-Young Her; Tae-Hwan Kim; Hyun-Kyu Chang; Woong-Soo Lee; Dae-Hyun Yoo
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

3.  Acquired amegakaryocytic thrombocytopenia as a rare cause of thrombocytopenia during pregnancy.

Authors:  Brittney S Zimmerman; Bridget Marcellino; Siraj M El Jamal; Anne S Renteria
Journal:  BMJ Case Rep       Date:  2019-06-21

4.  Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.

Authors:  A Meager; M Wadhwa; C Bird; P Dilger; R Thorpe; J Newsom-Davis; N Willcox
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

Review 5.  Dynamic hematological disease: a review.

Authors:  Catherine Foley; Michael C Mackey
Journal:  J Math Biol       Date:  2008-03-04       Impact factor: 2.259

6.  Autoimmune mice make anti-Fc gamma receptor antibodies.

Authors:  P Boros; J M Chen; C Bona; J C Unkeless
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

7.  Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura.

Authors:  E Mulroy; S Gleeson; S Chiruka
Journal:  Case Rep Hematol       Date:  2015-04-05

8.  Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.

Authors:  Takanori Ichikawa; Yasuhiro Shimojima; Toshiaki Otuki; Ken-Ichi Ueno; Dai Kishida; Yoshiki Sekijima
Journal:  Intern Med       Date:  2019-08-06       Impact factor: 1.271
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.